BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०१२
०.००%
(०.००) 1D
अक्टोबर २१, १२:२७:५८ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
३.९८ करोड
Avg. vol.
८०.५१ लाख
Volume
१०.९२ लाख
52-wk high
A$ ०.१६
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
३.९८ करोड
Avg. vol.
८०.५१ लाख
Volume
१०.९२ लाख
52-wk high
A$ ०.१६
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
The Motley Fool
·
६ मिनेट पहिले
How Long Could You Wait for the S&P 500 to Recover From a 10% Drop?
Moomoo
·
३९ मिनेट पहिले
Dow Jones Top Company Headlines at 9 PM ET: Larry Ellison Went on Borrowing Spree to Bankroll His Son's Warner Bros. Bid | Capital ...
Investor's Business Daily
·
१ घण्टा पहिले
Dow Jones Futures: AI Stocks Jump On SpaceX, Supermicro; Tesla, Meta On Deck
Seeking Alpha
·
२ घण्टा पहिले
Choppy Trading Leaves Dow Higher And Nasdaq Flat
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd